WHO/Q. Mattingly
© Credits

Antimicrobial resistance

    Overview

    Antimicrobial resistance (AMR) threatens the effective prevention and treatment of an ever-increasing range of infections caused by bacteria, parasites, viruses and fungi.

    Antimicrobial resistance happens when microorganisms (such as bacteria, fungi, viruses, and parasites) change when they are exposed to antimicrobial drugs (such as antibiotics, antifungals, antivirals, antimalarials, and anthelmintics). Microorganisms that develop antimicrobial resistance are sometimes referred to as “superbugs”.

    As a result, the medicines become ineffective and infections persist in the body, increasing the risk of spread to others.

    Global AMR response

    WHO's core mandate is to coordinate the global response in collaboration with key partners

    Addressing SDGs

    Mitigating AMR will have a huge impact on reaching 6 of the 17 sustainable development goals (SDGs)

    AMR & SDGs

    1.2 trillion USD

    additional health expenditure per year expected by 2050 due to the rise of antimicrobial resistance.

    "Together with our partners, we’re also stepping up the fight against antimicrobial resistance, one of the most urgent health threats of our time."

    Dr. Tedros Adhanom Ghebreyesus, WHO Director-General